Tealwood Asset Management Inc Neurocrine Biosciences Inc Transaction History

Tealwood Asset Management Inc

$228 Million
Q3 2024

A detailed history of Tealwood Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Tealwood Asset Management Inc holds 11,793 shares of NBIX stock, worth $1.6 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

11,793

Previous 11,899 0.89%

Holding current value

$1.6 Million

Previous $1.64 Million 17.03%

% of portfolio

0.59%

Previous 0.99%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$114.58 - $153.15 $12,145 - $16,233	-106 Reduced 0.89%	11,793 $1.36 Million
Q2 2024 Jul 09, 2024	SELL	$130.86 - $143.19 $14,263 - $15,607	-109 Reduced 0.91%	11,899 $1.64 Million
Q1 2024 Apr 11, 2024	SELL	$130.4 - $143.74 $32,208 - $35,503	-247 Reduced 2.02%	12,008 $1.66 Million
Q4 2023 Jan 08, 2024	SELL	$106.07 - $132.76 $23,229 - $29,074	-219 Reduced 1.76%	12,255 $1.62 Million
Q3 2023 Nov 08, 2023	SELL	$94.02 - $117.1 $33,941 - $42,273	-361 Reduced 2.81%	12,474 $1.4 Million
Q2 2023 Jul 26, 2023	SELL	$89.53 - $104.87 $19,607 - $22,966	-219 Reduced 1.68%	12,835 $1.21 Million
Q1 2023 Apr 12, 2023	BUY	$94.11 - $123.02 $2,729 - $3,567	29 Added 0.22%	13,054 $1.32 Million
Q4 2022 Jan 17, 2023	SELL	$106.72 - $127.06 $122,301 - $145,610	-1,146 Reduced 8.09%	13,025 $1.56 Million
Q3 2022 Nov 16, 2022	SELL	$92.03 - $107.81 $2,116 - $2,479	-23 Reduced 0.16%	14,171 $1.51 Million
Q2 2022 Jul 20, 2022	SELL	$75.79 - $100.07 $30,467 - $40,228	-402 Reduced 2.75%	14,194 $1.38 Million
Q1 2022 May 02, 2022	BUY	$72.45 - $94.81 $680,957 - $891,119	9,399 Added 180.85%	14,596 $1.37 Million
Q4 2021 Mar 15, 2022	SELL	$79.65 - $106.22 $560,258 - $747,151	-7,034 Reduced 57.51%	5,197 $443,000
Q3 2021 Dec 02, 2021	SELL	$86.18 - $99.03 $48,950 - $56,249	-568 Reduced 4.44%	12,231 $1.17 Million
Q1 2021 Jun 21, 2021	BUY	$87.57 - $119.4 $56,570 - $77,132	646 Added 5.32%	12,799 $1.25 Million
Q4 2020 Mar 09, 2021	BUY	$86.91 - $108.33 $532,845 - $664,171	6,131 Added 101.81%	12,153 $1.17 Million
Q3 2020 Dec 14, 2020	BUY	$96.16 - $135.15 $579,075 - $813,873	6,022 New	6,022 $579,000

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.

Account

Tealwood Asset Management Inc Neurocrine Biosciences Inc Transaction History